Dexcom Investor

Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.
Investors
Technology:
AgeTech
Industry:
Investor
Headquarters:
San Diego, California, United States
Founded Date:
1999-01-01
Employees Number:
5001-10000
Funding Status:
IPO
Investor Type:
For Profit
Number Of Exits:
1
Acquisitions Number:
3
Investors Number:
7
Total Funding:
$413,689,019
Estimated Revenue:
$100M to $500M
Last Funding Date:
2017-05-09
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership